Youcare Pharmaceutical released its 2026 interim report, with net profit attributable to the parent company at a loss of 105 million yuan, an expansion of 6.0698 million yuan compared with the same period last year. The company's total operating revenue was 1.181 billion yuan, up 1.18% year-on-year. Net cash inflow from operating activities was 9.5199 million yuan, an increase of 16.7424 million yuan year-on-year. The company's latest gross margin was 55.75%, up 6.18 percentage points year-on-year, and its latest ROE was -3.27%.
Youcare Pharmaceutical Group Co. Ltd. ANet loss of 105 million yuan, expanded from prior year, with negative ROE.
